naringenin has been researched along with Acute Myelogenous Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Du, X; Li, M; Lou, J; Shi, D; Xu, Y; Zhang, X; Zhuo, J | 1 |
1 other study(ies) available for naringenin and Acute Myelogenous Leukemia
Article | Year |
---|---|
Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Curcumin; Extracellular Signal-Regulated MAP Kinases; Flavanones; Humans; Leukemia, Myeloid, Acute; MAP Kinase Kinase 4; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Suppressor Protein p53 | 2015 |